Header Logo

Connection

Sue Leurgans to Cognition Disorders

Back to Details
This is a "connection" page, showing publications Sue Leurgans has written about Cognition Disorders.
Sue Leurgans
Connection Strength
3.219
Cognition Disorders
  1. Inability of plasma and urine F2A-isoprostane levels to differentiate mild cognitive impairment from Alzheimer's disease. Neurodegener Dis. 2010; 7(1-3):139-42.
    View in: PubMed
    Score: 0.220
  2. Effect of donepezil on motor and cognitive function in Huntington disease. Neurology. 2006 Oct 10; 67(7):1268-71.
    View in: PubMed
    Score: 0.174
  3. The association of MIND diet with cognitive resilience to neuropathologies. Alzheimers Dement. 2023 08; 19(8):3644-3653.
    View in: PubMed
    Score: 0.135
  4. Modifiable psychosocial risk factors and delayed onset of dementia in older populations: analysis of two prospective US cohorts. BMJ Open. 2022 04 04; 12(4):e059317.
    View in: PubMed
    Score: 0.127
  5. Proportion of cognitive loss attributable to terminal decline. Neurology. 2020 01 07; 94(1):e42-e50.
    View in: PubMed
    Score: 0.108
  6. Brain IGFBP-5 modifies the relation of depressive symptoms to decline in cognition in older persons. J Affect Disord. 2019 05 01; 250:313-318.
    View in: PubMed
    Score: 0.103
  7. Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline. Brain. 2017 03 01; 140(3):804-812.
    View in: PubMed
    Score: 0.089
  8. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease. Acta Neuropathol. 2017 03; 133(3):395-407.
    View in: PubMed
    Score: 0.087
  9. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016 08; 15(9):934-943.
    View in: PubMed
    Score: 0.085
  10. Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample. Mol Neurodegener. 2015 Dec 02; 10:65.
    View in: PubMed
    Score: 0.082
  11. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015 Dec 01; 85(22):1930-6.
    View in: PubMed
    Score: 0.081
  12. Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial. Mov Disord. 2015 Oct; 30(12):1657-63.
    View in: PubMed
    Score: 0.080
  13. Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging. 2015 Jul; 36(7):2225-2231.
    View in: PubMed
    Score: 0.078
  14. Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychology. 2015 May; 29(3):335-43.
    View in: PubMed
    Score: 0.077
  15. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging. 2014 Apr; 35(4):819-26.
    View in: PubMed
    Score: 0.070
  16. Cognitive decline in older persons initiating anticholinergic medications. PLoS One. 2013; 8(5):e64111.
    View in: PubMed
    Score: 0.069
  17. APOE e4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol Aging. 2013 Dec; 28(4):1015-23.
    View in: PubMed
    Score: 0.068
  18. Neuroticism modifies the association of vision impairment and cognition among community-dwelling older adults. Neuroepidemiology. 2013; 40(2):142-6.
    View in: PubMed
    Score: 0.066
  19. Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology. 2013; 40(2):73-84.
    View in: PubMed
    Score: 0.066
  20. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain. 2012 Oct; 135(Pt 10):3005-14.
    View in: PubMed
    Score: 0.066
  21. Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol Aging. 2013 Jan; 34(1):157-68.
    View in: PubMed
    Score: 0.064
  22. Increased fragmentation of rest-activity patterns is associated with a characteristic pattern of cognitive impairment in older individuals. Sleep. 2012 May 01; 35(5):633-40B.
    View in: PubMed
    Score: 0.064
  23. A genome-wide scan for common variants affecting the rate of age-related cognitive decline. Neurobiol Aging. 2012 May; 33(5):1017.e1-15.
    View in: PubMed
    Score: 0.062
  24. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol. 2011 Mar; 69(3):560-9.
    View in: PubMed
    Score: 0.059
  25. Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol. 2011 Mar; 68(3):351-6.
    View in: PubMed
    Score: 0.059
  26. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011 Mar; 42(3):722-7.
    View in: PubMed
    Score: 0.058
  27. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol. 2011 Feb; 69(2):320-7.
    View in: PubMed
    Score: 0.058
  28. Joint modeling of missing data due to non-participation and death in longitudinal aging studies. Stat Med. 2010 Sep 20; 29(21):2260-8.
    View in: PubMed
    Score: 0.057
  29. Neurodegenerative basis of age-related cognitive decline. Neurology. 2010 Sep 21; 75(12):1070-8.
    View in: PubMed
    Score: 0.057
  30. Telephone assessment of cognitive function in the late-onset Alzheimer's disease family study. Arch Neurol. 2010 Jul; 67(7):855-61.
    View in: PubMed
    Score: 0.056
  31. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease. Mov Disord. 2010 Feb 15; 25(3):401-4.
    View in: PubMed
    Score: 0.055
  32. Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J Am Geriatr Soc. 2010 Feb; 58(2):248-55.
    View in: PubMed
    Score: 0.054
  33. Congenital central hypoventilation syndrome: neurocognitive functioning in school age children. Pediatr Pulmonol. 2010 Jan; 45(1):92-8.
    View in: PubMed
    Score: 0.054
  34. Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. Arch Neurol. 2009 Nov; 66(11):1339-44.
    View in: PubMed
    Score: 0.054
  35. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology. 2009 Sep 22; 73(12):920-7.
    View in: PubMed
    Score: 0.053
  36. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009 Aug; 66(2):200-8.
    View in: PubMed
    Score: 0.053
  37. Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis. Neurology. 2007 Mar 06; 68(10):757-63.
    View in: PubMed
    Score: 0.045
  38. Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial. J Child Adolesc Psychopharmacol. 2006 Oct; 16(5):525-40.
    View in: PubMed
    Score: 0.043
  39. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging. 2006 May; 27(5):663-72.
    View in: PubMed
    Score: 0.040
  40. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging. 2004 Oct; 25(9):1197-203.
    View in: PubMed
    Score: 0.038
  41. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Arch Neurol. 2003 Aug; 60(8):1143-8.
    View in: PubMed
    Score: 0.035
  42. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2002 Feb 04; 443(2):136-53.
    View in: PubMed
    Score: 0.031
  43. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease. Acta Neuropathol Commun. 2018 05 01; 6(1):33.
    View in: PubMed
    Score: 0.024
  44. Memory complaints, dementia, and neuropathology in older blacks and whites. Ann Neurol. 2018 04; 83(4):718-729.
    View in: PubMed
    Score: 0.024
  45. Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol. 2016 09 01; 73(9):1062-9.
    View in: PubMed
    Score: 0.022
  46. Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition. Curr Alzheimer Res. 2013 Oct; 10(8):844-51.
    View in: PubMed
    Score: 0.018
  47. Hemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis. Neurology. 2011 Jul 19; 77(3):219-26.
    View in: PubMed
    Score: 0.015
  48. Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans. Arch Gen Psychiatry. 2010 May; 67(5):448-57.
    View in: PubMed
    Score: 0.014
  49. Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology. 2009 Apr 28; 72(17):1495-503.
    View in: PubMed
    Score: 0.013
  50. Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function. Neurobiol Aging. 2010 Jul; 31(7):1089-98.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.